These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1288944)

  • 1. Renpress, Sandopril (Spirapril/TI 211-950). Summary of chemical, pharmacological and clinical properties.
    Jerie P; Kremer HJ
    Cor Vasa; 1992; 34(1):82-7. PubMed ID: 1288944
    [No Abstract]   [Full Text] [Related]  

  • 2. Lisinopril for hypertension.
    Med Lett Drugs Ther; 1988 Apr; 30(763):41-2. PubMed ID: 2832713
    [No Abstract]   [Full Text] [Related]  

  • 3. Lisinopril--another ACE inhibitor.
    Drug Ther Bull; 1989 Apr; 27(8):31-2. PubMed ID: 2562398
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605
    [No Abstract]   [Full Text] [Related]  

  • 5. [A Czech and Slovak interventional study of spirapril (the CASSIS study). A randomized, double-blind, multicenter, placebo-controlled study in chronic heart failure].
    Jerie P; Kremer HJ; Uhlír O; Widimský J
    Vnitr Lek; 1997 Jun; 43(6):351-8. PubMed ID: 9601863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of heart failure with spirapril--the open phase of the CASSIS study. Analysis of the 2nd year extension of the CASSIS study].
    Widimský J; Jerie P; Kremer HJ; Uhlír O; Nikodýmová L
    Vnitr Lek; 1997 Jun; 43(6):359-62. PubMed ID: 9601864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lisinopril: a new ACE inhibitor for the treatment of hypertension and congestive heart failure.
    Chodoff L
    Mt Sinai J Med; 1990 May; 57(3):169-71. PubMed ID: 2164644
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new angiotensin-converting enzyme inhibitor is imminent].
    Michel D
    Fortschr Med; 1988 Jul; 106(22):463-6. PubMed ID: 2851512
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angioneurotic edema caused by angiotensin-converting enzyme inhibitors: incidence, clinical characteristics, mechanisms of action].
    Wernze H
    Z Kardiol; 1988; 77 Suppl 3():61-4. PubMed ID: 2850689
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in kidney function during treatment of heart failure patients with ACE inhibitors].
    Dietz R; Nagel F; Osterziel KJ
    Verh Dtsch Ges Inn Med; 1991; 97():545-8. PubMed ID: 1667051
    [No Abstract]   [Full Text] [Related]  

  • 11. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Modesti PA; Vanni S; Gensini GF
    Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of angiotensin-converting enzyme inhibitors and the future of cachexia therapy.
    von Haehling S; Sandek A; Anker SD
    J Am Geriatr Soc; 2005 Nov; 53(11):2030-1. PubMed ID: 16274392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

  • 14. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
    Haufe CC; Sierakowski B; Jansa U; Stein G
    Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of left ventricular hypertrophy by spirapril.
    Eichstädt H; Sierakowski B; Eskötter H; Cordes M; Kreuz D
    Blood Press Suppl; 1994; 2():93-4. PubMed ID: 8061856
    [No Abstract]   [Full Text] [Related]  

  • 16. Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure.
    Widimský J; Kremer HJ; Jerie P; Uhlír O
    Eur J Clin Pharmacol; 1995; 49(1-2):95-102. PubMed ID: 8751029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril: a new angiotensin-converting enzyme inhibitor.
    McRaith J; Fitz A
    Iowa Med; 1986 Oct; 76(10):482, 484, 486-8. PubMed ID: 3023256
    [No Abstract]   [Full Text] [Related]  

  • 18. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study].
    Widimský J; Lánská V; Hulínský V
    Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to treat heart failure.
    Lancet; 1992 Feb; 339(8788):278-9. PubMed ID: 1346289
    [No Abstract]   [Full Text] [Related]  

  • 20. [The value of lysinopril in cardiac insufficiency].
    Lambert M; Luccioni R
    Rev Prat; 1990 Oct; 40(23 Suppl):53-8. PubMed ID: 2176346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.